FDA Approves New Implanted Hearing Device
The Food and Drug Administration (FDA) has approved a new type of surgically implanted hearing device intended to help adults with moderate to severe nerve hearing loss. The device, the first of its kind, is an alternative to traditional hearing aids. Made by Symphonix Inc., of San Jose, Calif., the device is implanted behind the ear in the temporal bone. It takes sound and converts it to mechanical energy that is directly transferred to the middle ear. The energy vibrates in the middle ear, a process similar to normal sound. For more information visit www.fda.gov.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
